PNEUMACRIT Device for Neonatal Cardio Respiratory Monitoring
NCT ID: NCT06171867
Last Updated: 2024-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2023-11-24
2024-02-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Markers of Inflammation and Lung Recovery in ECMO Patients for PPHN
NCT02940327
Real-time State of Vigilance Monitor for the Neonatal Intensive Care Unit
NCT04920175
Infant Pulmonary Mechanics: High Flow Nasal Cannula Versus Nasal CPAP
NCT01939067
Electrocardiography Versus Pulse Oximetry for Newborn Heart Rate Determination
NCT01256346
Transcutaneous Carbon Dioxide Monitoring in Neonates Receiving Therapeutic Hypothermia for Neonatal Encephalopathy
NCT04603547
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Feasibility of the PNEUMACRIT belt
Neonates will be monitored with a PNEUMACRIT electrode belt for 6 to 24 hours. After the study period, patient parents and nurses will give feedback.
PNEUMACRIT
Monitoring of breathing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PNEUMACRIT
Monitoring of breathing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational age at birth over 32 weeks
* Weight 2000-5000g
* Postnatal age \> 12 hours
* Written informed consent from the parents of legal representative
* Non-invasive monitoring of oxygen saturation and ECG
Exclusion Criteria
* Weight at time of the study \< 2000g or \> 5000g
* Chest skin lesion preventing safe use of the electrode belt
* Recent chest surgery within the past 7 days (e.g. thoracotomy)
12 Hours
6 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Middlesex University
OTHER
University of Oulu
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Merja Kallio
MD, PhD, Principal investigator, Associate professor of pediatrics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oulu University Hospital
Oulu, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EETTMK: 73/2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.